NewAmsterdam Pharma Co N.V. (NAMS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $85.85M | -19.9% |
| 2024 | $107.12M | +82.5% |
| 2023 | $58.70M | +21.2% |
| 2022 | $48.43M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $85.85M | -19.9% |
| 2024 | $107.12M | +82.5% |
| 2023 | $58.70M | +21.2% |
| 2022 | $48.43M | — |